Impact of pneumatic tube vs. bicycle courier transport on platelet aggregation: influence of sex and diabetes

AimPneumatic tube (PT) transport can impact platelet function, often altering platelet aggregation. Consequently, manual transport is frequently recommended to mitigate preanalytical effects on platelet function tests. However, comparative data between PT and bicycle courier (BC) transport remain li...

Full description

Saved in:
Bibliographic Details
Main Authors: Hohneck, Anna (Author) , Kliemank, Elisabeth (Author) , Bach, Simon (Author) , Brings, Sebastian (Author) , Seebauer, Lukas (Author) , Roshan, Mani (Author) , Kender, Zoltan (Author) , Kopf, Stefan (Author) , Frey, Norbert (Author) , Zorn, Markus (Author) , Woerner, Stefan M. (Author) , Fleming, Thomas (Author) , Szendroedi, Julia (Author)
Format: Article (Journal)
Language:English
Published: 30 January 2026
In: Frontiers in medicine
Year: 2026, Volume: 12, Pages: 1-9
ISSN:2296-858X
DOI:10.3389/fmed.2025.1738634
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2025.1738634
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1738634/full
Get full text
Author Notes:Anna Hohneck, Elisabeth Kliemank, Simon Bach, Sebastian Brings, Lukas Seebauer, Mani Roshan, Zoltan Kender, Stefan Kopf, Norbert Frey, Markus Zorn, Stefan M. Woerner, Thomas Fleming and Julia Szendroedi
Description
Summary:AimPneumatic tube (PT) transport can impact platelet function, often altering platelet aggregation. Consequently, manual transport is frequently recommended to mitigate preanalytical effects on platelet function tests. However, comparative data between PT and bicycle courier (BC) transport remain limited, and it is unclear whether different agonist pathways or specific patient characteristics, such as sex and diabetes, modify transport-related effects.MethodsIn this study, two S-Monovette® 3.2% citrate syringes of whole blood were collected from 96 participants (43 female participants, 53 male participants; median age: 63 years). Samples were transported simultaneously by PT or BC to the Central Laboratory of University Hospital Heidelberg. Platelet function was assessed through light transmission aggregometry (LTA) using five diagnostically established agonists, including ADP, arachidonic acid, ristocetin, collagen, and epinephrine.ResultsBC transport was associated with small but statistically significant reductions in platelet aggregation compared with PT for several agonists: ADP (−2.5%, p = 0.02), arachidonic acid (−1.0%, p = 0.006), ristocetin (−2.0%, p = 0.003), and collagen (−3.0%, p = 0.002), while epinephrine-induced aggregation was unaffected (p = 0.58). These reductions were more pronounced in female patients and individuals with diabetes, particularly for collagen-induced aggregation (up to −3.5%, p = 0.02). Epinephrine-induced aggregation was unaffected by transport mode (p = 0.58). Females patients showed higher aggregation responses overall, especially to arachidonic acid (p = 0.02 vs. males). Among participants, antiplatelet drugs markedly inhibited ADP, arachidonic acid, and epinephrine-induced aggregation but did not meaningfully affect collagen or ristocetin responses.ConclusionPT transport resulted in minor increases in platelet aggregation compared with BC transport, which are unlikely to be clinically relevant for the majority of patients but may influence interpretation in selected subgroups, particularly in individuals with heightened platelet reactivity or borderline test results. The observed transport-related differences in female patients and individuals with diabetes suggest increased platelet mechanosensitivity in these groups and warrant confirmation in larger, dedicated studies.
Item Description:Gesehen am 10.03.2026
Physical Description:Online Resource
ISSN:2296-858X
DOI:10.3389/fmed.2025.1738634